Anika Therapeutics (ANIK) EBITDA (2010 - 2026)
Anika Therapeutics (ANIK) posted quarterly EBITDA of $3.0 million for Q2 2026, up 170.67% year-over-year from $1.1 million in Q2 2025, and up 153.83% quarter-over-quarter from -$5.5 million in Q1 2026.
Anika Therapeutics (ANIK) EBITDA (2010 - 2026) Analysis & Trends
Anika Therapeutics (ANIK) has reported EBITDA for 17 consecutive years, with $3.0 million the latest figure, recorded in Q2 2026.
- In Q2 2026, EBITDA rose 170.67% year-over-year to $3.0 million; the TTM figure through Jun 2026 stood at -$5.1 million (up 44.64% YoY), while the FY2025 annual figure was -$11.1 million, down 116.64% from the prior year.
- EBITDA advanced to $3.0 million in Q2 2026 per ANIK's latest filing, from -$5.5 million in the prior quarter.
- Across five years, EBITDA topped out at $24.7 million in Q4 2023 and bottomed at -$12.6 million in Q1 2023.
- Historically, EBITDA has averaged -$787333.3 across 5 years, with a median of -$3.3 million in 2022.
- Annual changes were most pronounced in 2022 — EBITDA soared 279.8% — and 2025, when it plunged 3891.36%.
- Anika Therapeutics' EBITDA stood at $16.4 million in 2022, then surged by 50.59% to $24.7 million in 2023, then slumped by 102.85% to -$705000.0 in 2024, then surged by 191.63% to $646000.0 in 2025, then surged by 357.28% to $3.0 million in 2026.
- Business Quant data shows ANIK's EBITDA at $3.0 million in Q2 2026, -$5.5 million in Q1 2026, and $646000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | -231.00 Mn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 837.00 Mn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | 1.26 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 330.80 Mn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | 6.30 Mn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 151.50 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 248.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Anika Therapeutics | 281.53 Mn | 243.12 Mn | 21.24 Mn | 2.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.95 Mn |
| Mar 31, 2026 | -5.49 Mn |
| Dec 31, 2025 | 646,000.00 |
| Sep 30, 2025 | -3.23 Mn |
| Jun 30, 2025 | -4.18 Mn |
| Mar 31, 2025 | -4.28 Mn |
| Dec 31, 2024 | -705,000.00 |
| Sep 30, 2024 | -81,000.00 |
| Jun 30, 2024 | -1.81 Mn |
| Mar 31, 2024 | -2.51 Mn |
| Dec 31, 2023 | 24.70 Mn |
| Sep 30, 2023 | -7.67 Mn |
| Jun 30, 2023 | -3.63 Mn |
| Mar 31, 2023 | -12.55 Mn |
| Dec 31, 2022 | 16.40 Mn |
| Sep 30, 2022 | -5.80 Mn |
| Jun 30, 2022 | -3.38 Mn |
| Mar 31, 2022 | -3.55 Mn |
| Dec 31, 2021 | -9.12 Mn |
| Sep 30, 2021 | 1.30 Mn |